Cargando…
Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells
Many drugs can cause unexpected muscle disorders, often necessitating the cessation of an effective medication. Inhibition of monocarboxylate transporters (MCTs) may potentially lead to perturbation of l-lactic acid homeostasis and muscular toxicity. Previous studies have shown that statins and lora...
Autores principales: | Leung, Yat Hei, Turgeon, Jacques, Michaud, Veronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750648/ https://www.ncbi.nlm.nih.gov/pubmed/28994701 http://dx.doi.org/10.3390/pharmaceutics9040042 |
Ejemplares similares
-
An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity
por: Alzghari, Saeed K
Publicado: (2018) -
Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise
por: Kwak, Hyo-Bum
Publicado: (2014) -
A Novel Mechanism to Explain Statin-Associated Skeletal Muscle Symptoms
por: Thompson, Paul D., et al.
Publicado: (2019) -
Modeling statin myopathy in a human skeletal muscle microphysiological system
por: Ananthakumar, Anandita, et al.
Publicado: (2020) -
The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy
por: Chung, Hae R., et al.
Publicado: (2016)